Investor's Calendar

May 2024

Mon Tue Wed Thu Fri Sat Sun
29
30
1
2
3
4
5
 
 
 
 
 
 
 
6
7
8
9
10
11
12
 
 
 
 
 
 
13
14
15
16
17
18
19
 
 
 
 
 
 
 
20
21
22
23
24
25
26
 
 
 
 
 
 
 
27
28
29
30
31
1
2
 
 
 
 
 
 
 

Last News

ROVI closes the quarter with operating revenue of 151.2 million euros
4 min
08 May, 2024
Agreement to manufacture pre-filled syringes for a global pharmaceutical company
3 min
25 Apr, 2024
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
4 min
02 Apr, 2024

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email